Skip to content

To find the efficacy of Brihat-Vridhadaruka Sama Churna and Navaka Guggulu in the management of Sthoulya(Obesity)

A Randomized Controlled Clinical Study to evaluate the efficacy of Brihat-Vridhadaruka Sama Churna and Navaka Guggulu in the management of Sthoulya w.s.r. to Obesity - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083376
Enrollment
60
Registered
2025-03-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E660- Obesity due to excess calories

Interventions

None listed

Sponsors

Institute for Ayurved studies and research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 The patient has signs and symptoms of Sthoulya explained in Ayurvedic texts. 2 Patients with the age group 18 60 years of both genders. 3 The patient having 10% excess weight than desirable weight according to height, sex, and age. 4 The patient with a BMI of 25 to 34.9. 5 Waist hip ratio: males more than 102 cm and females more than 88 cm 6 Ready to give written and informed consent.

Exclusion criteria

Exclusion criteria: 1 The patient is below 18 years and above 60 years of age of both genders. 2 The patient with a BMI of 35 and more than 35. 3 Patients suffering from diabetes mellitus, endocrinal disorders, cardiovascular diseases, hypertension, respiratory diseases, polycystic ovarian syndrome, and other such diseases in which the person cannot do his/her routine daily activities will be excluded. 4 Patients of Acute renal failure, chronic renal failure and Nephrotic syndrome. 5 Patients who have a known history of HIV, Hepatitis and other infectious diseases. 6 Patients with autoimmune disorders. 7 Pregnant and lactating mothers. 8 Alcoholics and other drug abusers. 9 Patient on prolonged medication with Corticosteroids, Antidepressants, Anticholinergic, Anticonvulsant, Antipsychotics, etc.

Design outcomes

Primary

MeasureTime frame
The proportion of the patient s showing improvement in the BMI level after the participation in study.Timepoint: 60 Days

Secondary

MeasureTime frame
1 Change in waist- hip ratio. 2 Change in quality of life.Timepoint: 75 days

Countries

India

Contacts

Public ContactDr Nisha

Institute for Ayurved Studies and Research

drlamba.neha@gmail.com9736333868

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026